Vasoactive Nutrients To Promote Healthy Ageing In Postmenopausal Women
Funder
National Health and Medical Research Council
Funding Amount
$598,031.00
Summary
Poor circulatory function in the brain, associated with mood and cognitive disturbances, can be further exacerbated by ageing and estrogen deprivation at postmenopause. My research will determine whether phytoestrogen supplementation with either resveratrol or genistein for 2 years can counteract menopause-related impairments in mood and mental performance by enhancing cerebral vasodilator function and whether the magnitude of improvement differs between early and late menopausal years.
Maternal Ophthalmic Artery Doppler Waveform Analysis In The Assessment And Management Of Pre-eclampsia
Funder
National Health and Medical Research Council
Funding Amount
$94,758.00
Summary
Pre-eclampsia is the commonest serious medical problem in pregnancy. Mothers who have this condition are at risk of seizures, stroke and other neurological problems, which can cause death or long-term morbidity. Treatments for pre-eclampsia aim to prevent these problems. Through ultrasound imaging of a blood vessel at the back of the eye, this study will provide new insights into how these treatments change the brain's blood supply in mothers with pre-eclampsia.
Predicting Intrapartum Fetal Compromise At Term Using The Fetal Cerebro-umbilical Ratio And Placental Growth Factor Levels
Funder
National Health and Medical Research Council
Funding Amount
$86,733.00
Summary
A lack of oxygen to a baby after the onset of labour (i.e. fetal distress) in an otherwise healthy pregnancy is one of the top three causes of death in singleton pregnancies after 37 weeks. Our previous research has shown that a late pregnancy ultrasound scan combined with a blood test from the mother measuring the levels of a placental hormone can potentially identify pregnancies at risk. We aim to assess the value of this screening test at a major tertiary hospital.
Improving Inner Retinal Oxygenation: Developing A New Form Of Retinal Laser Photocoagulation Therapy
Funder
National Health and Medical Research Council
Funding Amount
$408,818.00
Summary
Diabetic retinopathy is the major cause of vision loss in the working age population in our community. Current therapy involves laser destruction of much of the peripheral retina to protect the central vision. However, recent clinical and experimental evidence suggests that more moderate laser therapy could be sufficient, and that useful vision in the laser treated area can be preserved. Benefits to the patient would include reduced loss of visual field, and reduced night blindness.